Alerts will be sent to your verified email
Verify Email
CHEMOPH
|
Starsource Multitrad
|
Norris Medicines
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-4.44 % | 25.68 % | 10.99 % |
|
5yr average Equity Multiplier
|
1.01 | -1.27 | 1.23 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.6 | 0.25 |
|
5yr Avg Net Profit Margin
|
0.0 | -27.67 % | 77.44 % |
|
Price to Book
|
10.43 | 0.0 | 1.88 |
|
P/E
|
0.0 | 0.0 | 63.5 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 113.0 Days | 63.13 Days |
|
Inventory Days
|
0.0 | 182.62 Days | 54.75 Days |
|
Days Receivable
|
0.0 | 77.44 Days | 11.98 Days |
|
Days Payable
|
0.0 | 195.35 Days | 169.78 Days |
|
5yr Average Interest Coverage Ratio
|
670.55 | -1.07 | 820.35 |
|
5yr Avg ROCE
|
-2.98 % | -18.91 % | 17.27 % |
|
5yr Avg Operating Profit Margin
|
0.0 | -2.35 % | -130.11 % |
|
5 yr average Debt to Equity
|
0.01 | -1.84 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | -24.21 % | -26.08 % |
|
5yr Average Return on Assets
|
-4.07 % | -17.47 % | 8.75 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
27.89 % | 34.0 % | 59.53 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.04 % | 3.22 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Starsource Multitrad
|
Norris Medicines
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|